Teva Pharmaceutical Industries Ltd. (TEVA)

11.57
0.19 1.62
NYSE : Health Technology
Prev Close 11.76
Open 11.80
Day Low/High 11.20 / 11.94
52 Wk Low/High 6.07 / 13.76
Volume 11.69M
Avg Volume 10.87M
Exchange NYSE
Shares Outstanding 1.10B
Market Cap 12.57B
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Merger Mania Benefits Mylan

Merger Mania Benefits Mylan

Whether it's acquiring or the acquired, Mylan is building shareholder value.

The Election Cycle Is Good for Stocks

The Election Cycle Is Good for Stocks

Investing during a mid-term election can offer large returns.

Off the Charts

Off the Charts

We raised our stops on Teva and added Staples to the long ideas table.

Teva's Prospects Are Looking Up

Teva's Prospects Are Looking Up

It is preserving its Copaxone franchise, and the executive changes are good news.

Waiting for the Fed

In a flattish market, transports are strong on FedEx's earnings, and small-caps are underperforming. By Bret Jensen The market pretty is flat ahead of the FOMC release. Transports are strong on FedEx's (FDX) earnings, and small-caps are underperform...

Examining Two Pharmaceutical Stocks

Examining Two Pharmaceutical Stocks

Conflicting technical patterns suggest one is healthy and the other could be under the weather.

Teva Is a Trade Opportunity

Teva Is a Trade Opportunity

 Stocks with good fundamentals are getting some respect.

It's Time to Duck

It's Time to Duck

A pullback of at least 10%, seems like a distinct possibility.

Teva added to US Focus List at Citi

Teva upgraded at Goldman

Teva upgraded at JP Morgan

Teva upgraded at Leerink

Time to Analyze Small-Caps Again

Time to Analyze Small-Caps Again

These three carry nice valuations.

Teva Has Upside to Capture

Teva Has Upside to Capture

The pharma company looks suitable for a buy-write combination trade.

5 Dumbest Things on Wall Street

5 Dumbest Things on Wall Street

Muddy's Return, Lost & Blankfein, McDonald's Ketchup Caper, Sears Tears and Tough Times at Teva highlight Gregg Greenberg's Dumbest list.

Bulls Take a Breather

Bulls Take a Breather

The bears won a rare victory on Wall Street as the Fed left rates unchanged. Ranger Equity Bear Fund Manager Brad Lamensdorf names shorts.

Stocks Fall on Taper Uncertainty

Stocks Fall on Taper Uncertainty

Markets closed lower as the Fed maintained stimulus as expected, with growing uncertainty around the wind-down of bond purchases.

Looking Across the Pond

Looking Across the Pond

Some European names look ripe for investment right now.

Playing the Fed Just Like Earnings

Playing the Fed Just Like Earnings

Game the event, not the pregame.

Tap Into Teva, Foot Locker

Tap Into Teva, Foot Locker

Teva, Foot Locker, Williams and IP offer a nice mix of yield and upside, says Martin Sass, portfolio manager for the MD Sass Equity Income Plus Fund.

Teva downgraded at Morgan Stanley

The Real Tech Boom Is Under Way

The Real Tech Boom Is Under Way

This sector offers the best growth opportunity over the next decade.

Consider Teva While It's Down

Consider Teva While It's Down

The pharma stock is cheap, and it's a turnaround story.

Cooper Tire Sells to Apollo Tyres

Cooper Tire Sells to Apollo Tyres

Cooper Tire & Rubber is being acquired by India's Apollo Tyres Ltd. in a move that will create the seventh-largest tire company in the world.

The Real Tech Boom Is Still Just Beginning

The Real Tech Boom Is Still Just Beginning

If you're overly cautious about biotech, you could incur some major opportunity costs.

Teva downgraded at Wells

Teva downgraded at Canaccord